The true impacts of the price cuts will be seen by how GLP-1RA manufacturers adjust prices to remain competitive, market ...

Novo Nordisk's Martin Holst Lange preveiwed the company's obesity pill, while OpenAI launches new initiative to speed up ...

Ozempic and Zepbound have helped Novo Nordisk and Eli Lilly achieve a combined market cap topping $900 billion.

Lawsuit: Woman shot by security guard while leaving restaurant Travis Kelce's Coach Had One Question About Hard Slap During Game in Brazil US Issues New Warning Over Italian Tiremaker’s Chinese Owner ...

Novo Nordisk's Q2 growth, strong market share, and innovative drug pipeline make it a top stock pick. Click here to find out ...

Discover why Novo Nordisk is a top buy with strong GLP-1 drug growth, robust fundamentals, and defensive value.

The World Health Organization added Novo Nordisk A/S’s Ozempic and Eli Lilly & Co.’s Mounjaro to its list of essential ...

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO).

Denmark’s Novo Nordisk announced a significant price cut last month for its blockbuster drug, Ozempic (semaglutide), which is ...

The INFORM real-world evidence study shows impact of semaglutide on reducing ‘food noise’, and the STEP UP clinical trial ...

The World Health Organization (WHO) recommended a range of blockbuster weight-loss drugs to treat diabetes and obesity ...